Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01907802
Title Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

Advanced Solid Tumor

Therapies

Dabrafenib

Age Groups: adult | senior
Covered Countries USA | CAN

Additional content available in CKB BOOST